According to OncoTherapy Science latest financial reports the cash on hand of 4564 is $7.80M, an decrease of -39.16% to 2022. At the end of 2022 company had $12.82M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $7.80M | -39.16% |
2022 | $12.82M | -36.64% |
2021 | $20.24M | -38.50% |
2020 | $32.90M | -2.96% |
2019 | $33.91M | - |